APOA1 and fatty liver disease: TRF significantly reduced serum TG, TC, and ApoA-1 levels but had no effect on LDL levels (Figure 4C), indicating that TRF lowers serum lipid levels, which may contribute to its protective effect against hepatic steatosis.